HIT Consultant July 26, 2024
Fred Pennic

What You Should Know:

Avenda Health, a pioneer in AI-powered prostate cancer care, announced today that the Centers for Medicare & Medicaid Services (CMS) has assigned a national payment rate for its prostate cancer mapping technology, Unfold AI.

– This significant development, alongside the establishment of a new Category III code by the American Medical Association (AMA), paves the way for broader adoption of Unfold AI and improved prostate cancer diagnosis and treatment.

Unfold AI: A Game-Changer in Prostate Cancer Detection

Using a patient’s standard of care data (MRI, fusion biopsy, pathology and PSA) and artificial intelligence, Unfold AI generates a heatmap or Cancer Estimation Map (CEM) that visualizes where the cancer is in 3D, significantly outperforming...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), CMS, Govt Agencies, Provider, Technology
Archetype AI’s Newton model learns physics from raw data—without any help from humans
Salesforce CEO Marc Beinoff slams Microsoft Copilot as ‘Clippy 2.0’
Ten Years of AI Venture Capital Deals and Exits
Where Trump & Harris Stand on Payers, AI, Drug Pricing and CMS
Harvard’s super-selective AI track

Share This Article